Clinical Trial Update: Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether an antibody-mediated IL-6 inhibition reduces inflammation in patients with advanced chronic kidney disease. Results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Anti-IL-6 antibody (investigational)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Chronic Kidney Diseases, Inflammation | Phase 2 | Status: COMPLETED | Results posted: 2023-08-09